Market Cap (In TWD)
1.7 Billion
Revenue (In TWD)
72.83 Million
Net Income (In TWD)
-10.13 Million
Avg. Volume
317.63 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 25.35-39.3
- PE
- -1017.5
- EPS
- -0.04
- Beta Value
- 0.845
- ISIN
- TW0006649007
- CUSIP
- -
- CIK
- -
- Shares
- 42000000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Healthcare
- CEO
- Dr. Wen-Hsi Wang
- Employee Count
- -
- Website
- https://www.twbm.com.tw
- Ipo Date
- 2017-08-29
- Details
- Taiwan Biomaterial Co., Ltd. engages in the development and sale of medical devices in Taiwan. The company provides Foamagen, a foamy dura substitute; stroke thrombus negative pressure removal catheter system comprising suction and removal of cerebrovascular embolism blood clot for the pump system, and the nickel-titanium guidewire for guiding cerebral vascular surgery; and tissue repair and regeneration products for the treatment of early osteoarthritis. Taiwan Biomaterial Co., Ltd. Was founded in 2010 and is based in Zhubei, Taiwan.
More Stocks
-
KINGSINFRKings Infra Ventures Limited
KINGSINFR
-
UAVS
-
EFOIEnergy Focus, Inc.
EFOI
-
8123T.Kawabe & Co., Ltd.
8123
-
7738EUI
7738
-
VMRI
-
002145
-
300006